CardioDynamics and Philips in co-development deal:
This article was originally published in Clinica
CardioDynamics has formed a co-development and OEM agreement with Philips Medical Systems. The deal will combine San Diego, California-based CardioDynamics' proprietary impedance cardiography (ICG) technology with Philips' diagnostic 12-lead technology. "We have long believed that coupling ICG with ECG will increase the utility and further drive the adoption of our clinically-proven technology," said Michael Perry, CardioDynamics' CEO.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.